The use of 16,16‐dimethyl‐transδ2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra‐amniotic prostaglandin E2
- 1 November 1984
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 91 (11), 1136-1140
- https://doi.org/10.1111/j.1471-0528.1984.tb15090.x
Abstract
The use of gemeprost pessaries has been compared in an open randomized trial with the extra-amniotic infusion of prostaglandin E2 (PGE2) for the termination of pregnancy between 12 and 16 weeks gestation. The success rates were 77% and 79% for the pessary and infusion group respectively, and these rates were unaffected by parity. There was no significant difference in the cumulative abortion rate between the two groups, nor were there differences in the induction-abortion interval, nor in the time taken to the onset of pain or bleeding. However, women in the pessary group required significantly less analgesia than those in the infusion group. Side-effects, experienced both during treatment and during the 6 weeks after abortion, were similar in both groups. Gemeprost vaginal pessaries are an effective alternative to the extra-amniotic infusion of PGE2 for the termination of pregnancy in the early second trimester.Keywords
This publication has 15 references indexed in Scilit:
- A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatationContraception, 1980
- THE USE OF 16–16 DIMETHYL TRANS Δ2 PGE1 METHYL ESTER (ONO 802) VAGINAL SUPPOSITORIES FOR THE TERMINATION OF EARLY PREGNANCY. A OMPARATIVE STUDYBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Induction of second trimester abortion: Comparison between vaginal 15-methyl-PGF2α methyl ester and intra-amniotic PGF2αProstaglandins, 1978
- Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancyContraception, 1977
- Vaginally administered 16,16-dimethyl-PGE2 for the induction of midtrimester abortionProstaglandins, 1976
- INTRA-AMNIOTIC UREA AND LOW-DOSE PROSTAGLANDIN E2 FOR MID-TRIMESTER TERMINATIONThe Lancet, 1975
- Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragmProstaglandins, 1974
- TERMINATION OF PREGNANCY BY CONTINUOUS INTRAUTERINE INFUSION OF PROSTAGLANDINSThe Lancet, 1972
- THERAPEUTIC ABORTION AND INDUCTION OF LABOUR BY THE INTRAVAGINAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2αBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970